Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Device Center Change May Cast Shadow On Woodcock's Future At CDER

This article was originally published in The Tan Sheet

Executive Summary

The pharmaceutical industry should weigh the resignation of Center for Devices and Radiological Health Director Dan Schultz in the context of what it means for their interactions with FDA's drug and biologics centers

You may also be interested in...

FDA Enforcement Follow-Through Could Thin Out Violators

FDA's emphasis on follow-through in its revamped enforcement strategy may help weed out bad actors from legitimate industry

Generic Lovenox In EU Will Require Clinical Data, Shrinking Sandoz’s Opportunity

An EU guidance issued earlier this year requiring clinical trials for generic copies of low molecular weight heparins may just have shot the European market opportunity for Momenta and its partner Sandoz, according to Momenta's CFO Rick Shea

FDA Scientists Say Plan B Decision-Makers At CDER “Should Be Removed”

A group of FDA scientists is calling for the removal of agency leaders who are suspected of politically motivated decisions regarding the emergency contraceptive Plan B





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts